CN104432052A - 一种能抗疲劳防衰老的保健胶囊及其制备方法 - Google Patents
一种能抗疲劳防衰老的保健胶囊及其制备方法 Download PDFInfo
- Publication number
- CN104432052A CN104432052A CN201410772513.4A CN201410772513A CN104432052A CN 104432052 A CN104432052 A CN 104432052A CN 201410772513 A CN201410772513 A CN 201410772513A CN 104432052 A CN104432052 A CN 104432052A
- Authority
- CN
- China
- Prior art keywords
- parts
- health
- minute
- preparation
- minutes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002775 capsule Substances 0.000 title claims abstract description 51
- 238000002360 preparation method Methods 0.000 title claims description 31
- 230000036541 health Effects 0.000 title abstract description 13
- 230000032683 aging Effects 0.000 title abstract 2
- 235000000832 Ayote Nutrition 0.000 claims abstract description 42
- 235000009854 Cucurbita moschata Nutrition 0.000 claims abstract description 42
- 235000009804 Cucurbita pepo subsp pepo Nutrition 0.000 claims abstract description 42
- 235000015136 pumpkin Nutrition 0.000 claims abstract description 42
- 240000008042 Zea mays Species 0.000 claims abstract description 37
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims abstract description 37
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims abstract description 36
- 235000005822 corn Nutrition 0.000 claims abstract description 36
- 235000009496 Juglans regia Nutrition 0.000 claims abstract description 33
- 235000020234 walnut Nutrition 0.000 claims abstract description 33
- 239000003814 drug Substances 0.000 claims abstract description 31
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 24
- 241000110637 Cuscuta chinensis Species 0.000 claims abstract description 22
- 235000015468 Lycium chinense Nutrition 0.000 claims abstract description 21
- 235000008708 Morus alba Nutrition 0.000 claims abstract description 20
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 20
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 20
- 235000021323 fish oil Nutrition 0.000 claims abstract description 20
- 235000008434 ginseng Nutrition 0.000 claims abstract description 20
- 239000000203 mixture Substances 0.000 claims abstract description 16
- 229940079593 drug Drugs 0.000 claims abstract description 15
- 240000007049 Juglans regia Species 0.000 claims abstract 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 48
- 230000002929 anti-fatigue Effects 0.000 claims description 32
- 230000003005 anti-senility effect Effects 0.000 claims description 32
- 210000000582 semen Anatomy 0.000 claims description 23
- 241000167550 Centella Species 0.000 claims description 20
- 108010010803 Gelatin Proteins 0.000 claims description 20
- 244000241872 Lycium chinense Species 0.000 claims description 20
- 229920000159 gelatin Polymers 0.000 claims description 20
- 239000008273 gelatin Substances 0.000 claims description 20
- 235000019322 gelatine Nutrition 0.000 claims description 20
- 235000011852 gelatine desserts Nutrition 0.000 claims description 20
- 241000112528 Ligusticum striatum Species 0.000 claims description 19
- 241000218231 Moraceae Species 0.000 claims description 19
- 240000004371 Panax ginseng Species 0.000 claims description 19
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 18
- 238000009835 boiling Methods 0.000 claims description 18
- 239000002245 particle Substances 0.000 claims description 18
- 150000003839 salts Chemical class 0.000 claims description 14
- 238000003756 stirring Methods 0.000 claims description 14
- 230000001954 sterilising effect Effects 0.000 claims description 12
- 238000004659 sterilization and disinfection Methods 0.000 claims description 12
- 240000001980 Cucurbita pepo Species 0.000 claims description 9
- 238000005516 engineering process Methods 0.000 claims description 9
- 229910052742 iron Inorganic materials 0.000 claims description 9
- 240000007594 Oryza sativa Species 0.000 claims description 8
- 235000007164 Oryza sativa Nutrition 0.000 claims description 8
- 239000012467 final product Substances 0.000 claims description 8
- 235000009566 rice Nutrition 0.000 claims description 8
- 206010013786 Dry skin Diseases 0.000 claims description 7
- 238000001035 drying Methods 0.000 claims description 7
- 239000007788 liquid Substances 0.000 claims description 7
- 239000000155 melt Substances 0.000 claims description 7
- 238000005507 spraying Methods 0.000 claims description 7
- 239000000052 vinegar Substances 0.000 claims description 7
- 235000021419 vinegar Nutrition 0.000 claims description 7
- 230000000694 effects Effects 0.000 abstract description 16
- 239000000463 material Substances 0.000 abstract description 3
- 230000000144 pharmacologic effect Effects 0.000 abstract description 3
- 241000219122 Cucurbita Species 0.000 abstract description 2
- 244000241838 Lycium barbarum Species 0.000 abstract description 2
- 235000015459 Lycium barbarum Nutrition 0.000 abstract description 2
- 240000000249 Morus alba Species 0.000 abstract description 2
- 210000000988 bone and bone Anatomy 0.000 abstract description 2
- 230000002708 enhancing effect Effects 0.000 abstract description 2
- 230000036039 immunity Effects 0.000 abstract description 2
- 230000001737 promoting effect Effects 0.000 abstract description 2
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 208000003643 Callosities Diseases 0.000 abstract 1
- 244000146462 Centella asiatica Species 0.000 abstract 1
- 235000004032 Centella asiatica Nutrition 0.000 abstract 1
- 206010020649 Hyperkeratosis Diseases 0.000 abstract 1
- 241000212322 Levisticum officinale Species 0.000 abstract 1
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 241000756042 Polygonatum Species 0.000 abstract 1
- 235000008737 Polygonatum biflorum Nutrition 0.000 abstract 1
- 235000007215 black sesame Nutrition 0.000 abstract 1
- 239000003292 glue Substances 0.000 abstract 1
- 239000001645 levisticum officinale Substances 0.000 abstract 1
- 239000002994 raw material Substances 0.000 abstract 1
- 230000002195 synergetic effect Effects 0.000 abstract 1
- 240000004244 Cucurbita moschata Species 0.000 description 31
- 241000758789 Juglans Species 0.000 description 28
- 239000008280 blood Substances 0.000 description 22
- 210000004369 blood Anatomy 0.000 description 20
- 230000006870 function Effects 0.000 description 14
- 210000004185 liver Anatomy 0.000 description 14
- 229940112824 paste Drugs 0.000 description 14
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 12
- 230000007812 deficiency Effects 0.000 description 12
- 208000002173 dizziness Diseases 0.000 description 11
- 210000000952 spleen Anatomy 0.000 description 10
- 201000010099 disease Diseases 0.000 description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 9
- 235000013305 food Nutrition 0.000 description 9
- 210000003734 kidney Anatomy 0.000 description 9
- 235000009508 confectionery Nutrition 0.000 description 8
- 206010016256 fatigue Diseases 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 7
- 206010022437 insomnia Diseases 0.000 description 7
- 206010011224 Cough Diseases 0.000 description 6
- 208000002193 Pain Diseases 0.000 description 6
- 210000004072 lung Anatomy 0.000 description 6
- 230000036407 pain Effects 0.000 description 6
- 206010010774 Constipation Diseases 0.000 description 5
- 206010019233 Headaches Diseases 0.000 description 5
- 206010028980 Neoplasm Diseases 0.000 description 5
- 208000027418 Wounds and injury Diseases 0.000 description 5
- 239000010839 body fluid Substances 0.000 description 5
- 231100000869 headache Toxicity 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 230000035922 thirst Effects 0.000 description 5
- 208000025865 Ulcer Diseases 0.000 description 4
- 206010052428 Wound Diseases 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 4
- 210000001124 body fluid Anatomy 0.000 description 4
- 235000012000 cholesterol Nutrition 0.000 description 4
- 201000001881 impotence Diseases 0.000 description 4
- 210000003205 muscle Anatomy 0.000 description 4
- 235000016709 nutrition Nutrition 0.000 description 4
- 230000035764 nutrition Effects 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 231100000397 ulcer Toxicity 0.000 description 4
- 208000000059 Dyspnea Diseases 0.000 description 3
- 206010013975 Dyspnoeas Diseases 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 206010033557 Palpitations Diseases 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- 229930182558 Sterol Natural products 0.000 description 3
- 206010046788 Uterine haemorrhage Diseases 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 206010003246 arthritis Diseases 0.000 description 3
- 210000004556 brain Anatomy 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 210000003414 extremity Anatomy 0.000 description 3
- 150000004676 glycans Chemical class 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 208000019423 liver disease Diseases 0.000 description 3
- 230000027939 micturition Effects 0.000 description 3
- 210000005036 nerve Anatomy 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 210000003491 skin Anatomy 0.000 description 3
- 230000002269 spontaneous effect Effects 0.000 description 3
- 150000003432 sterols Chemical class 0.000 description 3
- 235000003702 sterols Nutrition 0.000 description 3
- 239000011800 void material Substances 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 206010013935 Dysmenorrhoea Diseases 0.000 description 2
- 206010013954 Dysphoria Diseases 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- WRACWYWAPQQRKC-UHFFFAOYSA-N Madasiatic acid Chemical compound C1C(O)C(O)C(C)(C)C2C(O)CC3(C)C4(C)CCC5(C(O)=O)CCC(C)C(C)C5C4=CCC3C21C WRACWYWAPQQRKC-UHFFFAOYSA-N 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- 208000037093 Menstruation Disturbances Diseases 0.000 description 2
- 206010027339 Menstruation irregular Diseases 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- 208000009205 Tinnitus Diseases 0.000 description 2
- 206010047513 Vision blurred Diseases 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 230000001914 calming effect Effects 0.000 description 2
- 230000035568 catharsis Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000000857 drug effect Effects 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- FBUKVWPVBMHYJY-UHFFFAOYSA-N nonanoic acid Chemical compound CCCCCCCCC(O)=O FBUKVWPVBMHYJY-UHFFFAOYSA-N 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 231100000862 numbness Toxicity 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000035900 sweating Effects 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 231100000886 tinnitus Toxicity 0.000 description 2
- 230000001256 tonic effect Effects 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- PEYUIKBAABKQKQ-AFHBHXEDSA-N (+)-sesamin Chemical compound C1=C2OCOC2=CC([C@H]2OC[C@H]3[C@@H]2CO[C@@H]3C2=CC=C3OCOC3=C2)=C1 PEYUIKBAABKQKQ-AFHBHXEDSA-N 0.000 description 1
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- XBZYWSMVVKYHQN-MYPRUECHSA-N (4as,6as,6br,8ar,9r,10s,12ar,12br,14bs)-10-hydroxy-2,2,6a,6b,9,12a-hexamethyl-9-[(sulfooxy)methyl]-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicene-4a-carboxylic acid Chemical compound C1C[C@H](O)[C@@](C)(COS(O)(=O)=O)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C XBZYWSMVVKYHQN-MYPRUECHSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- ZGXJTSGNIOSYLO-UHFFFAOYSA-N 88755TAZ87 Chemical compound NCC(=O)CCC(O)=O ZGXJTSGNIOSYLO-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 206010049865 Achromotrichia acquired Diseases 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 208000000044 Amnesia Diseases 0.000 description 1
- 208000031091 Amnestic disease Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- MQVRGDZCYDEQML-UHFFFAOYSA-N Astragalin Natural products C1=CC(OC)=CC=C1C1=C(OC2C(C(O)C(O)C(CO)O2)O)C(=O)C2=C(O)C=C(O)C=C2O1 MQVRGDZCYDEQML-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- SGNBVLSWZMBQTH-FGAXOLDCSA-N Campesterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@H](C(C)C)C)C)CC4)CC3)CC=2)CC1 SGNBVLSWZMBQTH-FGAXOLDCSA-N 0.000 description 1
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 208000017897 Carcinoma of esophagus Diseases 0.000 description 1
- 206010008111 Cerebral haemorrhage Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 241000282994 Cervidae Species 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 241000207782 Convolvulaceae Species 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- PQMOXTJVIYEOQL-UHFFFAOYSA-N Cumarin Natural products CC(C)=CCC1=C(O)C(C(=O)C(C)CC)=C(O)C2=C1OC(=O)C=C2CCC PQMOXTJVIYEOQL-UHFFFAOYSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- 206010013789 Dry throat Diseases 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- 208000000461 Esophageal Neoplasms Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 239000001263 FEMA 3042 Substances 0.000 description 1
- 208000012895 Gastric disease Diseases 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- 208000008899 Habitual abortion Diseases 0.000 description 1
- BTEISVKTSQLKST-UHFFFAOYSA-N Haliclonasterol Natural products CC(C=CC(C)C(C)(C)C)C1CCC2C3=CC=C4CC(O)CCC4(C)C3CCC12C BTEISVKTSQLKST-UHFFFAOYSA-N 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 208000031361 Hiccup Diseases 0.000 description 1
- OVSQVDMCBVZWGM-SJWGPRHPSA-N Hyperin Natural products O[C@H]1[C@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-SJWGPRHPSA-N 0.000 description 1
- FVQOMEDMFUMIMO-UHFFFAOYSA-N Hyperosid Natural products OC1C(O)C(O)C(CO)OC1OC1C(=O)C2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 FVQOMEDMFUMIMO-UHFFFAOYSA-N 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 208000005016 Intestinal Neoplasms Diseases 0.000 description 1
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 1
- 206010024229 Leprosy Diseases 0.000 description 1
- 241000234280 Liliaceae Species 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- WYQVAPGDARQUBT-FGWHUCSPSA-N Madecassol Chemical compound O([C@@H]1[C@@H](CO)O[C@H]([C@@H]([C@H]1O)O)OC[C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)OC(=O)[C@]12CC[C@H]([C@@H]([C@H]1C=1[C@@]([C@@]3(CC[C@H]4[C@](C)(CO)[C@@H](O)[C@H](O)C[C@]4(C)[C@H]3CC=1)C)(C)CC2)C)C)[C@@H]1O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O WYQVAPGDARQUBT-FGWHUCSPSA-N 0.000 description 1
- BNMGUJRJUUDLHW-HCZMHFOYSA-N Madecassoside Chemical compound O([C@@H]1[C@@H](CO)O[C@H]([C@@H]([C@H]1O)O)OC[C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)OC(=O)[C@]12CC[C@H]([C@@H]([C@H]1C=1[C@@]([C@@]3(C[C@@H](O)[C@H]4[C@](C)(CO)[C@@H](O)[C@H](O)C[C@]4(C)[C@H]3CC=1)C)(C)CC2)C)C)[C@@H]1O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O BNMGUJRJUUDLHW-HCZMHFOYSA-N 0.000 description 1
- BNMGUJRJUUDLHW-HLUHVYOBSA-N Madecassoside Natural products C[C@@H]1CC[C@@]2(CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)C[C@@H](O)[C@H](O)[C@@](C)(CO)[C@@H]5[C@H](O)C[C@@]34C)[C@@H]2[C@H]1C)C(=O)O[C@@H]6O[C@H](CO[C@@H]7O[C@H](CO)[C@@H](O[C@@H]8O[C@H](C)[C@H](O)[C@@H](O)[C@H]8O)[C@H](O)[C@H]7O)[C@@H](O)[C@H](O)[C@H]6O BNMGUJRJUUDLHW-HLUHVYOBSA-N 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 208000019914 Mental Fatigue Diseases 0.000 description 1
- FSOGIJPGPZWNGO-UHFFFAOYSA-N Meomammein Natural products CCC(C)C(=O)C1=C(O)C(CC=C(C)C)=C(O)C2=C1OC(=O)C=C2CCC FSOGIJPGPZWNGO-UHFFFAOYSA-N 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- 101100455539 Mus musculus Lsp1 gene Proteins 0.000 description 1
- 208000002454 Nasopharyngeal Carcinoma Diseases 0.000 description 1
- 206010061306 Nasopharyngeal cancer Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- IOVCWXUNBOPUCH-UHFFFAOYSA-N Nitrous acid Chemical compound ON=O IOVCWXUNBOPUCH-UHFFFAOYSA-N 0.000 description 1
- 208000015914 Non-Hodgkin lymphomas Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 241000037831 Polygonatum sibiricum Species 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- 241000282806 Rhinoceros Species 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- 206010039966 Senile dementia Diseases 0.000 description 1
- 238000003457 Shi epoxidation reaction Methods 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 241000208292 Solanaceae Species 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 208000024770 Thyroid neoplasm Diseases 0.000 description 1
- 206010043866 Tinea capitis Diseases 0.000 description 1
- HZYXFRGVBOPPNZ-UHFFFAOYSA-N UNPD88870 Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)=CCC(CC)C(C)C)C1(C)CC2 HZYXFRGVBOPPNZ-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000003044 adaptive effect Effects 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- FSLPMRQHCOLESF-UHFFFAOYSA-N alpha-amyrenol Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C)C(C)C5C4=CCC3C21C FSLPMRQHCOLESF-UHFFFAOYSA-N 0.000 description 1
- 230000006986 amnesia Effects 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 1
- 150000004056 anthraquinones Chemical class 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- WYQVAPGDARQUBT-XCWYDTOWSA-N asiaticoside Natural products O=C(O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@H]2[C@H](O)[C@H](O)[C@H](O[C@H]3[C@H](O)[C@H](O)[C@@H](O)[C@H](C)O3)[C@@H](CO)O2)O1)[C@@]12[C@@H]([C@@H](C)[C@H](C)CC1)C=1[C@](C)([C@@]3(C)[C@@H]([C@@]4(C)[C@H]([C@@](CO)(C)[C@@H](O)[C@H](O)C4)CC3)CC=1)CC2 WYQVAPGDARQUBT-XCWYDTOWSA-N 0.000 description 1
- QCYLIQBVLZBPNK-UHFFFAOYSA-N asiaticoside A Natural products O1C(C(=O)C(C)C)=CC(C)C(C2(C(OC(C)=O)CC34C5)C)C1CC2(C)C3CCC(C1(C)C)C45CCC1OC1OCC(O)C(O)C1O QCYLIQBVLZBPNK-UHFFFAOYSA-N 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 1
- JFSHUTJDVKUMTJ-QHPUVITPSA-N beta-amyrin Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C JFSHUTJDVKUMTJ-QHPUVITPSA-N 0.000 description 1
- QQFMRPIKDLHLKB-UHFFFAOYSA-N beta-amyrin Natural products CC1C2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C)CCC1(C)C QQFMRPIKDLHLKB-UHFFFAOYSA-N 0.000 description 1
- PDNLMONKODEGSE-UHFFFAOYSA-N beta-amyrin acetate Natural products CC(=O)OC1CCC2(C)C(CCC3(C)C4(C)CCC5(C)CCC(C)(C)CC5C4=CCC23C)C1(C)C PDNLMONKODEGSE-UHFFFAOYSA-N 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 230000000157 blood function Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 238000010322 bone marrow transplantation Methods 0.000 description 1
- 210000004958 brain cell Anatomy 0.000 description 1
- 230000003925 brain function Effects 0.000 description 1
- 235000021152 breakfast Nutrition 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- SGNBVLSWZMBQTH-PODYLUTMSA-N campesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](C)C(C)C)[C@@]1(C)CC2 SGNBVLSWZMBQTH-PODYLUTMSA-N 0.000 description 1
- 235000000431 campesterol Nutrition 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 206010007625 cardiogenic shock Diseases 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N coumarin Chemical compound C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- PEYUIKBAABKQKQ-UHFFFAOYSA-N epiasarinin Natural products C1=C2OCOC2=CC(C2OCC3C2COC3C2=CC=C3OCOC3=C2)=C1 PEYUIKBAABKQKQ-UHFFFAOYSA-N 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 230000004345 fruit ripening Effects 0.000 description 1
- 230000005714 functional activity Effects 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 208000023513 hiccough Diseases 0.000 description 1
- 230000000971 hippocampal effect Effects 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 208000021822 hypotensive Diseases 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 201000002313 intestinal cancer Diseases 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- DLRVVLDZNNYCBX-RTPHMHGBSA-N isomaltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-RTPHMHGBSA-N 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- JPUKWEQWGBDDQB-QSOFNFLRSA-N kaempferol 3-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=CC(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O JPUKWEQWGBDDQB-QSOFNFLRSA-N 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 210000002414 leg Anatomy 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 229940118199 levulan Drugs 0.000 description 1
- 230000005976 liver dysfunction Effects 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 235000012680 lutein Nutrition 0.000 description 1
- 239000001656 lutein Substances 0.000 description 1
- 229960005375 lutein Drugs 0.000 description 1
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 description 1
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 description 1
- 208000025036 lymphosarcoma Diseases 0.000 description 1
- PRAUVHZJPXOEIF-AOLYGAPISA-N madecassic acid Chemical compound C1[C@@H](O)[C@H](O)[C@@](C)(CO)[C@@H]2[C@H](O)C[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C PRAUVHZJPXOEIF-AOLYGAPISA-N 0.000 description 1
- PRAUVHZJPXOEIF-UHFFFAOYSA-N madecassica acid Natural products C1C(O)C(O)C(C)(CO)C2C(O)CC3(C)C4(C)CCC5(C(O)=O)CCC(C)C(C)C5C4=CCC3C21C PRAUVHZJPXOEIF-UHFFFAOYSA-N 0.000 description 1
- 229940090813 madecassoside Drugs 0.000 description 1
- 235000009973 maize Nutrition 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000011733 molybdenum Substances 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 230000004118 muscle contraction Effects 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 201000011216 nasopharynx carcinoma Diseases 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 235000019488 nut oil Nutrition 0.000 description 1
- 239000010466 nut oil Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 201000010041 presbyopia Diseases 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- OVSQVDMCBVZWGM-DTGCRPNFSA-N quercetin 3-O-beta-D-galactopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-DTGCRPNFSA-N 0.000 description 1
- BBFYUPYFXSSMNV-UHFFFAOYSA-N quercetin-7-o-galactoside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=C2C(=O)C(O)=C(C=3C=C(O)C(O)=CC=3)OC2=C1 BBFYUPYFXSSMNV-UHFFFAOYSA-N 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 210000001525 retina Anatomy 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 230000005070 ripening Effects 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- VRMHCMWQHAXTOR-CMOCDZPBSA-N sesamin Natural products C1=C2OCOC2=CC([C@@H]2OC[C@@]3(C)[C@H](C=4C=C5OCOC5=CC=4)OC[C@]32C)=C1 VRMHCMWQHAXTOR-CMOCDZPBSA-N 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 230000003860 sleep quality Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- HCXVJBMSMIARIN-PHZDYDNGSA-N stigmasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)[C@@]1(C)CC2 HCXVJBMSMIARIN-PHZDYDNGSA-N 0.000 description 1
- 235000016831 stigmasterol Nutrition 0.000 description 1
- 229940032091 stigmasterol Drugs 0.000 description 1
- BFDNMXAIBMJLBB-UHFFFAOYSA-N stigmasterol Natural products CCC(C=CC(C)C1CCCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C BFDNMXAIBMJLBB-UHFFFAOYSA-N 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 201000000498 stomach carcinoma Diseases 0.000 description 1
- 229910052712 strontium Inorganic materials 0.000 description 1
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 1
- 229940033123 tannic acid Drugs 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 201000002510 thyroid cancer Diseases 0.000 description 1
- 208000009189 tinea favosa Diseases 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 230000004304 visual acuity Effects 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 1
- 229940052228 zinc oxide paste Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
本发明公开了一种能抗疲劳防衰老的保健胶囊,各原料药如下,均为重量份:阿胶5-15,积雪草6-12,玉米12-25,南瓜8-16,桑葚子6-12,川芎5-15,龙骨3-7,枸杞子7-15,黑芝麻10-20,核桃仁3-9,菟丝子9-15,人参5-15,玉竹3-12,深海鱼油3-8,当归10-20。本发明提供中药方剂组方科学,选取了具有增强免疫力、有助于睡眠等药效的天然中药材,通过其药效发挥协同作用,本发明中药方剂具有疗效好,见效快,治愈率高等特点。
Description
技术领域
本发明属中医中药领域,尤其是涉及一种能抗疲劳防衰老的保健胶囊及其制备方法。
背景技术
现代中医认为,疲劳为一个病名,有其病因病机,是临床上常见病、多发病,是必须重视的新病种,归于亚健康范畴,涉及五脏六腑,主要以脾、肝、肾为主。可以通过中医辨证组方调治,以达到预防、治疗、控制的目的。疲劳为元气耗伤之虚证与心理变化(或不畅)双重因素所致。治疗上不仅要补虚扶正,也应祛疲安神。一方面,补虚固元,滋养机体,虚得补,正则旺,疲劳自除;另一方面,调畅心志,舒心畅意,神得安,心则宁,疲劳可消。疲劳是一个很常见的现象,既可见于健康人群、亚健康人群,又可见于很多疾病人群,也可因某些医疗措施( 如癌症放疗、化疗后、骨髓移植后或使用某些生物制剂后) 所导致。由于疲劳可不同程度地影响人们的生活质量,因此,随着医学模式的转变及对生活质量的逐步重视,对疲劳的研究也越来越受到研究者的关注。
亚健康是指介于健康及疾病之间的状态,处于亚健康状态者,不能达到健康的标准,表现为一定时间内的活力降低、功能和适应能力减退的症状,但不符合现代医学有关疾病的临床或亚临床诊断标准。亚健康的表现是多种多样的,其中“疲劳”为亚健康最主要的
表现之一。随着社会竞争的日趋激烈,生活节奏的逐步加快及居处环境的污染等,人们承受的压力越来越大,临床上,处于亚健康状态的人群越来越多,从而引起了研究者的广泛关注。近两年,国家在“十一五”科技支撑计划、“863”计划中立专项,进行亚健康的相关研究。疲劳或亚健康对人们生活、工作的影响及其高发生率,使得对其有效干预措施的需求日益突显。由于中医独特的理论体系,辨证论治的个体化诊疗思想,以及丰富的干预手段,使得中医药在调治疲劳及亚健康方面有着得天独厚的优势。研究证明,疲劳的产生与中医肝、脾两脏关系甚为密切。脾主运化和四肢肌肉,思虑或劳倦过度可损伤脾,导致脾运失常;肝藏血主疏泄,藏血功能可维护其疏泄功能,若肝血不足,可致肝失疏泄,则影响肝调畅气机的功能,从而影响脾脏化生精微、主四肢肌肉的功能。
近几年来中药在能抗疲劳防衰老方面取得了很好的疗效,但是其制备方法都比较复杂,大多数是汤剂,众所周知,汤剂不方便携带,而且纯中药汤剂非常的苦,不容易下咽。
发明内容
针对现有能抗疲劳防衰老方法的不足,本发明的目的之一在于提供一种能抗疲劳防衰老的保健胶囊,在服用本药治疗过程中,见效快,且无副作用,在改善头晕、头痛以及失眠症状的同时,还能够增强免疫力,是一种能抗疲劳防衰老的理想保健胶囊。
本发明的另一目的就是提供上述能抗疲劳防衰老的保健胶囊的制备方法。
本发明的上述目的是通过以下技术方案来实现的:
一种能抗疲劳防衰老的保健胶囊,各原料药如下,均为重量份:阿胶5-15,积雪草6-12,玉米12-25,南瓜8-16,桑葚子6-12,川芎5-15,龙骨3-7,枸杞子7-15,黑芝麻10-20,核桃仁3-9,菟丝子9-15,人参5-15,玉竹3-12,深海鱼油3-8,当归10-20。
一种能抗疲劳防衰老的保健胶囊,优选的方案,各原料药如下,均为重量份:阿胶8-13,积雪草8-10,玉米16-21,南瓜12-14,桑葚子8-10,川芎8-13,龙骨4-6,枸杞子10-12,黑芝麻13-18,核桃仁5-7,菟丝子11-13,人参8-13,玉竹5-10,深海鱼油4-6,当归13-18。
一种能抗疲劳防衰老的保健胶囊,更佳优选的方案,各原料药如下,均为重量份:阿胶10,积雪草9,玉米18,南瓜13,桑葚子9,川芎10,龙骨5,枸杞子11,黑芝麻15,核桃仁6,菟丝子12,人参11,玉竹8,深海鱼油5,当归15。
一种能抗疲劳防衰老的保健胶囊的制备方法,步骤如下:
①将龙骨置于80-100℃的热水中,待水温冷却至室温时,加入食盐,待食盐完全融化后,浸泡10-30分钟(优选20分钟),取出晾干,用粉碎机粉碎成细末待用;
②取当归和川芎洗净,沥干水分,高温杀菌1-5分钟,切片,用米醋喷淋均匀,稍闷10分钟后与枸杞子、黑芝麻和核桃仁混匀,置烧干的热锅内用微火炒3-8分钟,取出,放置室温时,研磨成细末待用;
③将积雪草、桑葚子、菟丝子、人参和玉竹置于瓦片上,小火慢烘10-30分钟,晾凉研磨成细末,过80-120目筛(优选100目筛);
④将南瓜洗净,切成硬币大小的块待用;
⑤将玉米淘洗1-3次,加玉米重量8-12倍的水,浸泡1小时后加入深海鱼油和阿胶,大火煮沸后加入步骤④所得南瓜块,大火煮沸4-8分钟后,兑入冷水,转文火煎煮20-40分钟,用铁勺慢慢搅拌,待搅拌至南瓜成为稠状物时,加入步骤①-③所得细末,充分搅拌成稠膏;
⑥将步骤⑤所得稠膏在50-70℃干燥10-18小时,制成颗粒,将制备成的颗粒按照胶囊的制备工艺包装即得。
上述保健胶囊的制备方法,步骤①将龙骨置于85-95℃的热水中(优选将龙骨置于90℃的热水中)。
上述保健胶囊的制备方法,步骤②高温杀菌2-4分钟(优选高温杀菌3分钟)。
上述保健胶囊的制备方法,步骤③小火慢烘15-25分钟(优选小火慢烘20分钟)。
上述保健胶囊的制备方法,步骤⑤加玉米重量9-11倍的水(优选加玉米重量10倍的水)。
上述保健胶囊的制备方法,步骤⑤大火煮沸5-7分钟后,兑入冷水,转文火煎煮25-35分钟(优选大火煮沸6分钟后,兑入冷水,转文火煎煮30分钟)。
上述保健胶囊的制备方法,步骤⑥稠膏在55-65℃干燥12-16小时,制成颗粒(优选稠膏在60℃干燥14小时,制成颗粒)。
本发明对抗疲劳防衰老的效果显著,为使本发明达到最佳的治疗效果,每日3次,分别于三餐后半小时服用,每次2粒,温开水送服,10天为一个疗程。
各原料药的药理功效分别为:
阿胶:阿胶,补血滋阴,润燥,止血。用于血虚萎黄,眩晕心悸,心烦不眠,肺燥咳嗽。血滋阴,润燥,止血。用于血虚萎黄,眩晕心悸,心烦不眠,肺燥咳嗽。
积雪草:基原:为双子叶植物伞形科积雪草的干燥全草或带根全草。成分:含多种α-香树脂醇型的三萜成分,其中有积雪草苷、参枯尼苷、异参枯尼苷,羟基积雪草苷,玻热模苷、破热米苷和破热米酸等,以及马达积雪草酸。药性:苦、辛,寒。归肝、脾、肾经。功用主治:清热解毒,利湿消肿。是东方人的长寿药,可益脑提神。研究表明具有滋补、消炎、愈合伤口、利尿通便和镇定作用。对麻风病、溃疡也有疗效,对血液净化及免疫力有激活作用,因其可刺激深层皮肤细胞的更替。它是神经滋补剂,能提高记忆力,减轻精神疲劳;还可降血压,治疗肝病等。
玉米:玉米是粗粮中的保健佳品,对人体的健康颇为有利:玉米中的维生素B6、烟酸等成分,具有刺激胃肠蠕动、加速粪便排泄的特性,可防治便秘、胃病、肠炎、肠癌等。玉米富含维生素C、异麦芽低聚糖等,有长寿、美容作用。玉米胚尖所含的营养物质有增强人体新陈代谢、调整神经系统功能。能起到使皮肤细嫩光滑,抑制、延缓皱纹产生作用。玉米有调中开胃及降血脂、降低血清胆固醇的功效。中美洲印第安人不易患高血压与他们主要食用玉米有关。
南瓜:南瓜不仅有较高的食用价值,而且有着不可忽视的食疗作用。据《滇南本草》载:南瓜性温,味甘无毒,入脾、胃二经,能润肺益气,化痰排脓,驱虫解毒,治咳止喘,疗肺痈便秘,并有利尿、美容等作用。南瓜分泌的胆汁可以促进肠胃蠕动,帮助食物消化,同时其中的果胶可以让人免受粗糙食品的刺激,保护我们的胃胶道粘膜。另外南瓜可以使肝、肾功能得到恢复以及再生的能力,因为南瓜可以消除致癌物质亚硝酸的突变作用。南瓜中还有一种“钴”的成分,食用后有补血作用。南瓜含有丰富的维生素A、b、c及矿物质,必需的8种氨基酸和儿童必需的组氨酸,可溶性纤维、叶黄素和磷、钾、钙、镁、锌、硅等微量元素。近代营养学和医学表明,多食南瓜可有效防治高血压,糖尿病及肝脏病变,提高人体免疫能力。
桑葚子:基原:为桑科桑属植物桑的干燥果穗。成分:果穗含维生素B1、B2和胡萝卜素;其脂类的脂肪酸主要为亚油酸,油酸,软脂酸,硬脂酸,尚有少量辛酸,壬酸,癸酸等。药性:甘、酸、寒。归甘、肾经。功用主治:滋阴养血,生津,润肠。主治肝肾不足和血虚精亏的头晕目眩,耳鸣,须发早白,失眠,消渴,腰酸,肠燥便秘,秃疮。
川芎:行气开郁,法风燥湿,活血止痛。治风冷头痛旋晕,胁痛腹疼,寒痹筋挛,经闭,难产,产后瘀阻块痛,痈疽疮疡。用于月经不调,经闭痛经,瘕腹痛,胸胁刺痛,跌扑肿痛,头痛,风湿痹痛。
龙骨:基原:为古代哺乳动物象类、犀类、三趾马、牛类、鹿类等的骨骼化石。成分:龙骨主要含碳酸钙及磷酸钙,尚含有铁、钾、钠、氯、硫酸根等。药性:涩、甘,平。归心、肝、肾、大肠经。功用主治:镇心安神,平肝潜阳,收敛固涩。主治心悸,怔肿,失眠,健忘,惊痫,癫狂,眩晕,自汗盗汗,遗精遗尿,崩漏带下,久泄久痢,溃疡久不收口及湿疮。
枸杞子:枸杞子,为茄科植物枸杞的成熟果实。夏、秋果实成熟时采摘,除去果柄,置阴凉处晾至果皮起皱纹后,再暴晒至外皮干硬、果肉柔软即得。遇阴雨可用微火烘干。具有多种保健功效,是卫生部批准的药食两用食物。主治滋补肝肾,益精明目。用于虚劳精亏,腰膝酸痛,眩晕耳鸣,内热消渴,血虚萎黄,目昏不明。
黑芝麻:黑芝麻药食两用,具有“补肝肾,滋五脏,益精血,润肠燥”等保健功效,被视为滋补圣品。一方面是因为含有优质蛋白质和丰富的矿物质,另一方面是因为含有丰富的不饱和脂肪酸、维生素E和珍贵的芝麻素及黑色素。
核桃仁:核桃仁为胡桃核内的果肉,又名胡桃仁、胡桃肉。1、补虚强体,提供营养:经动物实验证明,含胡桃油的混合脂肪饮食,可使体重增长,血清白蛋白增加,而血胆固醇水平升高却较慢,故核桃是难得的一种高脂肪性物质的补养品。2、消炎杀菌,养护皮肤:桃核仁有直接的抑菌消炎作用。据临床报道,将核桃仁捣烂制成的核桃焦油氧化锌糊膏,治疗皮炎、湿疹,有效率可达100%。核桃仁富含的油脂,有利于润泽肌肤,保持人体活力。3、防癌抗癌:实验证明,核桃有效成分对小鼠S37肿瘤有抑制作用。核桃技对多种肿瘤,如食道癌、胃癌、鼻咽癌、肺癌、甲状腺癌、淋巴肉瘤等都有一定的抑制作用。此外,核桃对癌症患者还有镇痛,提升白细胞及保护肝脏等作用。4、健脑防老:核桃仁含有较多的蛋白质及人体营养必需的不饱和脂肪酸,这些成分皆为大脑组织细胞代谢的重要物质,能滋养脑细胞,增强脑功能。5、净化血液,降低胆固醇:核桃仁能减少肠道对胆固醇的吸收。并可溶解胆固醇,排除血管壁内的“污垢杂质”使血液净化,从而为人体提供更好的新鲜血液。所以,核桃仁有防止动脉硬化,降低胆固醇的作用。此外,核桃还可用于治疗非胰岛素依赖型糖尿病。
菟丝子:基原:为旋花科菟丝子属植物菟丝子的全草。成分:菟丝子含生物碱、蒽醌、香豆素、黄酮、甙类、甾醇、鞣酸、糖类等。黄酮类有:槲皮素、紫云英甙、金丝桃甙;甾醇类有:胆甾醇、菜油甾醇、β-谷甾醇、豆甾醇、β-香树脂醇。亦含微量元素如锶、钼、钙、镁、铁、锰、锌、铜等以及多种氨基酸(种子中的游离氨基酸和水解后的总氨基酸为5.3%,其中必需氨基酸的含量占42.8%)。药性:微辛,甘,平,无毒。功用主治:补肾益精,养肝明目。适用于肝肾不足的腰膝筋骨酸痛,腿脚软弱无力、阳痿遗精、呓语、小便频数、尿有余沥、头晕眼花、视物不清、耳鸣耳聋以及妇女带下、习惯性流产等症。
人参:味甘、微苦,性温、平。归脾、肺经、心经。补气,固脱,生津,安神,益智。主治:体虚欲脱,肢冷脉微,脾虚食少,肺虚喘咳,津伤口渴,内热消渴,久病虚羸,惊悸失眠,阳痿宫冷;心力衰竭,心原性休克。用于气短喘促,心悸健忘,口渴多汗,食少无力,一切急慢性疾病及失血后引起的休克、虚脱。大补元气,固脱生津,安神。治劳伤虚损,食少,倦怠,反胃吐食,大便滑泄,虚咳喘促,自汗暴脱,惊悸,健忘,眩晕头痛,阳痿,尿频,消渴,妇女崩漏,小儿慢惊,及久虚不复,一切气血津液不足之证。
玉竹:基原:为百合科黄精属植物玉竹的根茎。成分:①多糖类:根茎含玉竹黏多糖,玉竹果聚糖A、B、C、D,寡多糖。②甾族化合物:黄精螺甾醇,黄精螺甾醇苷等。药性:甘,平。归肺、胃经。功用主治:滋阴润肺,养胃生津。主治燥咳,劳嗽,热病阴伤,咽干口渴,消渴,阴虚外感,头昏眩晕,筋脉挛痛。
深海鱼油:1、调节血脂,清理血栓,防止血液凝固,预防脑血栓、脑溢血及中风。2、预防关节炎、缓解痛风、哮喘,暂时缓解由关节炎引起的肿痛。3、预防老年痴呆症、营养大脑、改善记忆。4、改善视力、防治老花眼。5、维护视网膜。
当归:甘、辛、温,补血;活血;调经止痛;润燥滑肠。主血虚诸证;月经不调;经闭;痛经;症瘕结聚;崩漏;虚寒腹痛;痿痹;肌肤麻木;肠燥便难;赤痢后重;痈疽疮疡;跌扑损伤。
本发明提供中药方剂组方科学,选取了具有增强免疫力、有助于睡眠等药效的天然中药材,通过其药效发挥协同作用,本发明中药方剂具有疗效好,见效快,治愈率高等特点。
具体实施方式
下面结合实施例和实验例详细说明本发明的技术方案,但保护范围不被此限制。
实施例1:一种能抗疲劳防衰老的保健胶囊,各原料药如下,均为重量份(每份取10g):阿胶5,积雪草6,玉米12,南瓜8,桑葚子6,川芎5,龙骨3,枸杞子7,黑芝麻10,核桃仁3,菟丝子9,人参5,玉竹3,深海鱼油3,当归10。
一种能抗疲劳防衰老的保健胶囊,制备步骤如下:
①将龙骨置于80℃的热水中,待水温冷却至室温时,加入食盐,待食盐完全融化后,浸泡10分钟,取出晾干,用粉碎机粉碎成细末待用;
②取当归和川芎洗净,沥干水分,高温杀菌1分钟,切片,用米醋喷淋均匀,稍闷10分钟后与枸杞子、黑芝麻和核桃仁混匀,置烧干的热锅内用微火炒3分钟,取出,放置室温时,研磨成细末待用;
③将积雪草、桑葚子、菟丝子、人参和玉竹置于瓦片上,小火慢烘10分钟,晾凉研磨成细末,过80目筛;
④将南瓜洗净,切成硬币大小的块待用;
⑤将玉米淘洗1次,加玉米重量8倍的水,浸泡1小时后加入深海鱼油和阿胶,大火煮沸后加入步骤④所得南瓜块,大火煮沸4分钟后,兑入冷水,转文火煎煮20分钟,用铁勺慢慢搅拌,待搅拌至南瓜成为稠状物时,加入步骤①-③所得细末,充分搅拌成稠膏;
⑥将步骤⑤所得稠膏在50℃干燥10小时,制成颗粒,将制备成的颗粒按照胶囊的制备工艺包装即得。
实施例2:一种能抗疲劳防衰老的保健胶囊,各原料药如下,均为重量份(每份取10g):阿胶15,积雪草12,玉米25,南瓜16,桑葚子12,川芎15,龙骨7,枸杞子15,黑芝麻20,核桃仁9,菟丝子15,人参15,玉竹12,深海鱼油8,当归20。
一种能抗疲劳防衰老的保健胶囊,制备步骤如下:
①将龙骨置于100℃的热水中,待水温冷却至室温时,加入食盐,待食盐完全融化后,浸泡30分钟,取出晾干,用粉碎机粉碎成细末待用;
②取当归和川芎洗净,沥干水分,高温杀菌5分钟,切片,用米醋喷淋均匀,稍闷10分钟后与枸杞子、黑芝麻和核桃仁混匀,置烧干的热锅内用微火炒8分钟,取出,放置室温时,研磨成细末待用;
③将积雪草、桑葚子、菟丝子、人参和玉竹置于瓦片上,小火慢烘30分钟,晾凉研磨成细末,过120目筛;
④将南瓜洗净,切成硬币大小的块待用;
⑤将玉米淘洗3次,加玉米重量12倍的水,浸泡1小时后加入深海鱼油和阿胶,大火煮沸后加入步骤④所得南瓜块,大火煮沸8分钟后,兑入冷水,转文火煎煮40分钟,用铁勺慢慢搅拌,待搅拌至南瓜成为稠状物时,加入步骤①-③所得细末,充分搅拌成稠膏;
⑥将步骤⑤所得稠膏在70℃干燥18小时,制成颗粒,将制备成的颗粒按照胶囊的制备工艺包装即得。
实施例3:一种能抗疲劳防衰老的保健胶囊,各原料药如下,均为重量份(每份取10g):阿胶8,积雪草8,玉米16,南瓜12,桑葚子8,川芎8,龙骨4,枸杞子10,黑芝麻13,核桃仁5,菟丝子11,人参8,玉竹5,深海鱼油4,当归13。
一种能抗疲劳防衰老的保健胶囊,制备步骤如下:
①将龙骨置于85℃的热水中,待水温冷却至室温时,加入食盐,待食盐完全融化后,浸泡15分钟,取出晾干,用粉碎机粉碎成细末待用;
②取当归和川芎洗净,沥干水分,高温杀菌2分钟,切片,用米醋喷淋均匀,稍闷10分钟后与枸杞子、黑芝麻和核桃仁混匀,置烧干的热锅内用微火炒5分钟,取出,放置室温时,研磨成细末待用;
③将积雪草、桑葚子、菟丝子、人参和玉竹置于瓦片上,小火慢烘15分钟,晾凉研磨成细末,过90目筛;
④将南瓜洗净,切成硬币大小的块待用;
⑤将玉米淘洗1次,加玉米重量9倍的水,浸泡1小时后加入深海鱼油和阿胶,大火煮沸后加入步骤④所得南瓜块,大火煮沸5分钟后,兑入冷水,转文火煎煮25分钟,用铁勺慢慢搅拌,待搅拌至南瓜成为稠状物时,加入步骤①-③所得细末,充分搅拌成稠膏;
⑥将步骤⑤所得稠膏在55℃干燥12小时,制成颗粒,将制备成的颗粒按照胶囊的制备工艺包装即得。
实施例4:一种能抗疲劳防衰老的保健胶囊,各原料药如下,均为重量份(每份取10g):阿胶13,积雪草10,玉米21,南瓜14,桑葚子10,川芎13,龙骨6,枸杞子12,黑芝麻18,核桃仁7,菟丝子13,人参13,玉竹10,深海鱼油6,当归18。
一种能抗疲劳防衰老的保健胶囊,制备步骤如下:
①将龙骨置于95℃的热水中,待水温冷却至室温时,加入食盐,待食盐完全融化后,浸泡25分钟,取出晾干,用粉碎机粉碎成细末待用;
②取当归和川芎洗净,沥干水分,高温杀菌4分钟,切片,用米醋喷淋均匀,稍闷10分钟后与枸杞子、黑芝麻和核桃仁混匀,置烧干的热锅内用微火炒7分钟,取出,放置室温时,研磨成细末待用;
③将积雪草、桑葚子、菟丝子、人参和玉竹置于瓦片上,小火慢烘25分钟,晾凉研磨成细末,过110目筛;
④将南瓜洗净,切成硬币大小的块待用;
⑤将玉米淘洗3次,加玉米重量11倍的水,浸泡1小时后加入深海鱼油和阿胶,大火煮沸后加入步骤④所得南瓜块,大火煮沸7分钟后,兑入冷水,转文火煎煮35分钟,用铁勺慢慢搅拌,待搅拌至南瓜成为稠状物时,加入步骤①-③所得细末,充分搅拌成稠膏;
⑥将步骤⑤所得稠膏在65℃干燥16小时,制成颗粒,将制备成的颗粒按照胶囊的制备工艺包装即得。
实施例5:一种能抗疲劳防衰老的保健胶囊,各原料药如下,均为重量份(每份取10g):阿胶10,积雪草9,玉米18,南瓜13,桑葚子9,川芎10,龙骨5,枸杞子11,黑芝麻15,核桃仁6,菟丝子12,人参11,玉竹8,深海鱼油5,当归15。
一种能抗疲劳防衰老的保健胶囊,制备步骤如下:
①将龙骨置于90℃的热水中,待水温冷却至室温时,加入食盐,待食盐完全融化后,浸泡20分钟,取出晾干,用粉碎机粉碎成细末待用;
②取当归和川芎洗净,沥干水分,高温杀菌3分钟,切片,用米醋喷淋均匀,稍闷10分钟后与枸杞子、黑芝麻和核桃仁混匀,置烧干的热锅内用微火炒6分钟,取出,放置室温时,研磨成细末待用;
③将积雪草、桑葚子、菟丝子、人参和玉竹置于瓦片上,小火慢烘20分钟,晾凉研磨成细末,过100目筛;
④将南瓜洗净,切成硬币大小的块待用;
⑤将玉米淘洗2次,加玉米重量10倍的水,浸泡1小时后加入深海鱼油和阿胶,大火煮沸后加入步骤④所得南瓜块,大火煮沸6分钟后,兑入冷水,转文火煎煮30分钟,用铁勺慢慢搅拌,待搅拌至南瓜成为稠状物时,加入步骤①-③所得细末,充分搅拌成稠膏;
⑥将步骤⑤所得稠膏在60℃干燥14小时,制成颗粒,将制备成的颗粒按照胶囊的制备工艺包装即得。
试验例1 实施例5所得能抗疲劳防衰老的保健胶囊的临床应用:在4所医院筛选150例长期工作压力大,睡眠不规律以及易生病的人,其中女性75例,男性75例。试验之前1周,对该人群进行连续观察,记录症状及变化,随机分为两组,实验组及对照组,实验组服用本发明所得产品,对照组服用其他能抗疲劳防衰老的药物。疗效情况判定标准:有效:服用本品后,睡眠质量提高,心情舒畅,抵抗力增强;无效:服用本品后,无明显变化,还是失眠,抵抗力低下,结果如表1所示。
表1服用实施例5所得产品治疗效果验证
治疗效果:从表1可以明显看出,服用本发明实施例3所得能抗疲劳防衰老的保健胶囊的实验组的有效98例(98%),无效2例(2%)。而对照组的有效率仅达到70%,无效率却高达了30%,服用本发明所得能抗疲劳防衰老的保健胶囊的实验组明显优于服用其他药物的对照组。本发明保健胶囊不仅能抗疲劳防衰老,还能够由疲劳引起的头痛、恶心、乏力等症状,减轻患者的身体负担,是一种能抗疲劳防衰老的理想保健胶囊。
Claims (10)
1.一种能抗疲劳防衰老的保健胶囊,其特征在于:各原料药如下,均为重量份:阿胶5-15,积雪草6-12,玉米12-25,南瓜8-16,桑葚子6-12,川芎5-15,龙骨3-7,枸杞子7-15,黑芝麻10-20,核桃仁3-9,菟丝子9-15,人参5-15,玉竹3-12,深海鱼油3-8,当归10-20。
2.根据权利要求1所述的能抗疲劳防衰老的保健胶囊,其特征在于:各原料药如下,均为重量份:阿胶8-13,积雪草8-10,玉米16-21,南瓜12-14,桑葚子8-10,川芎8-13,龙骨4-6,枸杞子10-12,黑芝麻13-18,核桃仁5-7,菟丝子11-13,人参8-13,玉竹5-10,深海鱼油4-6,当归13-18。
3.根据权利要求1所述的能抗疲劳防衰老的保健胶囊,其特征在于:各原料药如下,均为重量份:阿胶10,积雪草9,玉米18,南瓜13,桑葚子9,川芎10,龙骨5,枸杞子11,黑芝麻15,核桃仁6,菟丝子12,人参11,玉竹8,深海鱼油5,当归15。
4.根据权利要求1-3任一项所述的能抗疲劳防衰老的保健胶囊的制备方法,其特征在于:步骤如下:
①将龙骨置于80-100℃的热水中,待水温冷却至室温时,加入食盐,待食盐完全融化后,浸泡10-30分钟(优选20分钟),取出晾干,用粉碎机粉碎成细末待用;
②取当归和川芎洗净,沥干水分,高温杀菌1-5分钟,切片,用米醋喷淋均匀,稍闷10分钟后与枸杞子、黑芝麻和核桃仁混匀,置烧干的热锅内用微火炒3-8分钟,取出,放置室温时,研磨成细末待用;
③将积雪草、桑葚子、菟丝子、人参和玉竹置于瓦片上,小火慢烘10-30分钟,晾凉研磨成细末,过80-120目筛(优选100目筛);
④将南瓜洗净,切成硬币大小的块待用;
⑤将玉米淘洗1-3次,加玉米重量8-12倍的水,浸泡1小时后加入深海鱼油和阿胶,大火煮沸后加入步骤④所得南瓜块,大火煮沸4-8分钟后,兑入冷水,转文火煎煮20-40分钟,用铁勺慢慢搅拌,待搅拌至南瓜成为稠状物时,加入步骤①-③所得细末,充分搅拌成稠膏;
⑥将步骤⑤所得稠膏在50-70℃干燥10-18小时,制成颗粒,将制备成的颗粒按照胶囊的制备工艺包装即得。
5.根据权利要求4所述的保健胶囊的制备方法,其特征在于:步骤①将龙骨置于85-95℃的热水中(优选将龙骨置于90℃的热水中)。
6.根据权利要求4所述的保健胶囊的制备方法,其特征在于:步骤②高温杀菌2-4分钟(优选高温杀菌3分钟)。
7.根据权利要求4所述的保健胶囊的制备方法,其特征在于:步骤③小火慢烘15-25分钟(优选小火慢烘20分钟)。
8.根据权利要求4所述的保健胶囊的制备方法,其特征在于:步骤⑤加玉米重量9-11倍的水(优选加玉米重量10倍的水)。
9.根据权利要求4所述的保健胶囊的制备方法,其特征在于:步骤⑤大火煮沸5-7分钟后,兑入冷水,转文火煎煮25-35分钟(优选大火煮沸6分钟后,兑入冷水,转文火煎煮30分钟)。
10.根据权利要求4所述的保健胶囊的制备方法,其特征在于:步骤⑥稠膏在55-65℃干燥12-16小时,制成颗粒(优选稠膏在60℃干燥14小时,制成颗粒)。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410772513.4A CN104432052A (zh) | 2014-12-16 | 2014-12-16 | 一种能抗疲劳防衰老的保健胶囊及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410772513.4A CN104432052A (zh) | 2014-12-16 | 2014-12-16 | 一种能抗疲劳防衰老的保健胶囊及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104432052A true CN104432052A (zh) | 2015-03-25 |
Family
ID=52879399
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410772513.4A Pending CN104432052A (zh) | 2014-12-16 | 2014-12-16 | 一种能抗疲劳防衰老的保健胶囊及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104432052A (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105816732A (zh) * | 2016-05-28 | 2016-08-03 | 孙明香 | 一种能抗疲劳防衰老的保健胶囊及其制备方法 |
CN106072587A (zh) * | 2016-07-15 | 2016-11-09 | 惠安华晨贸易有限公司 | 一种具有改善免疫力功能的保健食品及其制备方法 |
CN108497488A (zh) * | 2018-05-28 | 2018-09-07 | 广东药科大学 | 具有增强免疫、缓解疲劳的保健食品组合物及其制备方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101745034A (zh) * | 2008-12-10 | 2010-06-23 | 高莹 | 抗衰老延年益寿药 |
CN102319410A (zh) * | 2011-09-13 | 2012-01-18 | 成美娜 | 一种补气养血的中药组合物及其制备方法 |
CN104173819A (zh) * | 2014-09-13 | 2014-12-03 | 吕银兰 | 治疗青少年白发的药物 |
-
2014
- 2014-12-16 CN CN201410772513.4A patent/CN104432052A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101745034A (zh) * | 2008-12-10 | 2010-06-23 | 高莹 | 抗衰老延年益寿药 |
CN102319410A (zh) * | 2011-09-13 | 2012-01-18 | 成美娜 | 一种补气养血的中药组合物及其制备方法 |
CN104173819A (zh) * | 2014-09-13 | 2014-12-03 | 吕银兰 | 治疗青少年白发的药物 |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105816732A (zh) * | 2016-05-28 | 2016-08-03 | 孙明香 | 一种能抗疲劳防衰老的保健胶囊及其制备方法 |
CN106072587A (zh) * | 2016-07-15 | 2016-11-09 | 惠安华晨贸易有限公司 | 一种具有改善免疫力功能的保健食品及其制备方法 |
CN108497488A (zh) * | 2018-05-28 | 2018-09-07 | 广东药科大学 | 具有增强免疫、缓解疲劳的保健食品组合物及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101695376B (zh) | 预防糖尿病的保健食品 | |
CN103860969A (zh) | 一种增肥的中药 | |
CN105695258A (zh) | 一种含荔枝核皂苷的女性保健酒 | |
CN105166235A (zh) | 一种气血双补降三高的保健茶及其制备方法 | |
CN106562413A (zh) | 一种提高免疫力膏滋及其制备方法 | |
CN106387096A (zh) | 一种保健芝麻油及其制备方法 | |
CN106937741A (zh) | 一种脱脂亚麻籽粉防癌抗癌健康减肥法及其制备方法 | |
CN104069390A (zh) | 一种用于增肥的中药汤剂 | |
CN104432052A (zh) | 一种能抗疲劳防衰老的保健胶囊及其制备方法 | |
CN104522213A (zh) | 适宜三高人群饮用的茶饮及其制备方法 | |
CN105232987A (zh) | 一种促进神经外科术后康复的中药 | |
CN106822660A (zh) | 一种治疗心脑血管疾病的中药制剂 | |
CN104645063A (zh) | 一种治疗乳腺增生的丸剂及制备方法 | |
CN104645123A (zh) | 一种防治慢性肾功能衰竭的丸剂及制备方法 | |
CN104547494A (zh) | 治疗甲亢的中药组合物药酒及制备工艺 | |
CN108524861A (zh) | 一种治疗失眠的中药膏及其制备方法 | |
CN105233093A (zh) | 一种治疗胃下垂的中药片剂 | |
CN104547999A (zh) | 产后发汗用油 | |
CN104825879A (zh) | 临床护理用健脾补肾胶囊及制备方法 | |
CN104940719A (zh) | 一种缓解尿毒症的健脾补肾丸剂及其制备方法 | |
CN104474346A (zh) | 一种缓解因辐射导致的偏头疼的保健胶囊及其制备方法 | |
CN104784587A (zh) | 一种治疗内分泌失调型不孕的中药组合物及其制备方法 | |
CN105213897A (zh) | 一种增肥中药片剂 | |
CN105816732A (zh) | 一种能抗疲劳防衰老的保健胶囊及其制备方法 | |
CN105106600A (zh) | 一种促进因车祸致脑部外伤手术后愈合的组合物及制法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20150325 |